Pharmakey

Pharmakey Digital create customised Patient Access Programs to the Pharmaceutical industry. Tailored solutions specific to your requirements & budget.

[Merck @Merck]

We're committed to helping clinicians and patients attain their A1C goal early in #T2D disease progressions. Learn how: https://t.co/cAjwezSzwF #FocusOnA1C #2018ADA

[Roche @Roche]

We are pleased to announce positive results from a Phase III cancer #immunotherapy study for the initial treatment of small cell #lungcancer. https://t.co/Da30tMYzAk $ROG $RHHBY

[CSL @CSL]

Production of seasonal influenza vaccine has restarted at Seqirus in Melbourne to help meet Australia’s unprecedented demand for flu vaccine

[CSL @CSL]

Federal Health Minister @GregHuntMP toured the Seqirus vaccine manufacturing facility today to see first-hand how an additional 700,000 does of the influenza vaccine will be manufactured

[CSL @CSL]

The A-Z of CSL’s growth story in today’s @BusinessDay https://t.co/UshAboITXA

[Pharmakey @Pharmakey2]

BBC News: 'Remarkable' therapy beats terminal breast cancer I saw this on the BBC and thought you should see it:

'Remarkable' therapy beats terminal breast cancer - https://t.co/e6VIFt36wC

[Roche @Roche]

Partner with us to contribute to progress towards personalized healthcare. #BIO2018 https://t.co/S0k173xz0k

[Roche @Roche]

We value external innovation as highly as our own internal development. We are looking for opportunities in various areas. #BIO2018 https://t.co/pvqFtJqFhU

[Research Australia @ResAustralia]

Fantastic to see @GladysB NSW Govt announce a $150 million funding boost over 10 years for heart disease research yesterday. Such great news for such a critical area @BradHazzard @garryjennings @HeartAust @NSWHealth https://t.co/ALThz98DEh

[Merck @Merck]

ICYMI: Today we announced new data in #lungcancer, #kidneycancer and more at #ASCO18. See all of the highlights here: https://t.co/FFFaUpWtuM $MRK

[Microsoft ANZ @MicrosoftANZ]

The Department of Health Australia is improving outcomes for citizens and future generations by breaking down siloed information systems and providing access to relevant data and insights. Made possible with Dynamics 365. https://t.co/tHOudz7UOF #MSBusinessFwd

[Bayer U.S. 🇺🇸 @BayerUS]

#ASCO18 is not just about the data. While we’re here in Chicago, we’re also raising funds for @StBaldricks and childhood cancer research.

[Roche @Roche]

The discovery of a protein that hides tumour cells from our immune system is helping us to come up with new approaches to fight cancer: https://t.co/hPO12RjXlF #ImmunoOncology #ASCO18

[Boehringer Ingelheim @boehringerus]

We’re excited about the latest advancements in research from the #lungcancer community at #ASCO18! Visit booth 3047 for a patient’s perspective on the treatment journey #LCSM

[AstraZenecaUS @AstraZenecaUS]

Coming up today at #ASCO18: we’re looking forward to presenting new data from our Phase III trial in hairy cell #leukemia (HCL), a relatively rare, slow-growing blood cancer.

[Pfizer Inc. @pfizer]

Do you know the difference between a normal cell where the HER2 cells grow and divide normally and a HER2-positive cancer cell where cells grow and divide faster? #gastriccancer #breastcancer

[Johnson & Johnson @JNJNews]

#AI is proving to be up to 250 times more efficient than the traditional method of drug discovery for #JNJ researchers. Learn more: https://t.co/mtjGAdzEtw

[AstraZeneca @AstraZeneca]

Immuno-Oncology seeks to strengthen our body’s natural ability to protect itself by providing the immune system with tools to help fight #cancer #ASCO18

[Bristol Myers Squibb @bmsnews]

How do you treat 11,000 new cases of pediatric cancer with only five pediatric oncologists? Find out here https://t.co/sf1qwUohi7

[Roche @Roche]

Dr. Eric Walk explains how cancer #immunotherapy is redefining our expectations for patient outcomes: https://t.co/S9sliCkdGj #CancerResearch